Antiallergic Action of Magnolia Officinalis on Immediate Hypersensitivity Reaction

  • Published : 2001.06.01

Abstract

We studied the effect of aqueous extract of Magnolia officinalis bark (Magnoliaceae) (MOAE) on the immediate hypersensitivity reaction. MOAE (0.01 to 1g/kg) dose-dependently inhibited compound 48/80 induced systemic anaphylaxis in rats. MOAE (0.1 and 1g/kg) also significantly inhibited local immunoglobulin E (lgE)-mediated passive cutaneous anaphylactic reaction. When MOAE was pretreated at concentrations ranging from 0.01 to 1g/kg, the levels of plasma histamine were reduced in a dose-dependent manner. MOAE (0.001 to 1 mg/ml) dose-dependently inhibited the histamine release from rat peritoneal mast cells (RPMC) activated by compound 48/80 or anti-dinitrophenyl (DNP) Igl. The level of cyclic AMP (CAMP) in RPMC, when MOAE was added, significantly increased compared with that of the normal control. Moreover, MOAE (0.01 to 1 mg/ml) had a significant inhibitory effect on anti-DNP Igl-induced tumor necrosis factor-$\alpha$ production from RPMC. These results indicate that MOAE inhibits immediate hypersensitivity reaction in vivo and in vitro.

Keywords

References

  1. J. Biol. Chem. v.266 Structure/function relationships in the mast cell high-affinity receptor for IgE (FcεRI): Role of cytoplasmic domains Alber,G.;Miller,L.;Jelsema,C.;Varin-Blank,N.;Metzger,H.
  2. Acta Ohpthalmol. v.67 Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study Allansmith,M.R.;Baird,R.S.;Ross,R.N.;Barney,N.P.;Bloch,K.J.
  3. Mol. Pharmacol. v.38 Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells Bueb,J.L.;Mousli,M.C.;Bronner,C.;Rouot,B.;Landry,Y.
  4. J. Exp. Med. v.170 Interleukin 3-dependent and independent mast cells stimulated with lgE and antigen express multiple cytokines Burd,P.R.;Rogers,H.W.;Gordon,J.R.;Martin,C.A.;Jayaraman,S.;Wilson,S.D.;Dvorak,A.M.;Galli,S.J.;Dorf,M.E.
  5. Pharmacology and applications of chinese materia medica Chang,H.M.(ed.);But,P.P.H.(ed.)
  6. Br. J. Pharmacol. v.70 Some studies on the release of histamine from mast cells stimulated with polylysine Ennis,M.;Pearce,F.L.;Weston,P.M.
  7. Cur. Opin. Immunol. v.3 Cytokine production by mast cells and basophils Galli,S.J.;Gorden,J.R.;Wershil,B.K.
  8. Nature v.346 Mast cell as a source of both preformed and immunologically inducible TNF-α/cachectin Gorden,J.R.;Galli,S.J.
  9. J. Immunol. v.146 Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone lgE-mediatd activation and degranulation Gurish,M.F.;Ghildyal,N.;Arm,J.;Austen,K.F.;Avraham,S.;Reynolds,D.S.;Stevens,R.L.
  10. Biochem. Pharmac. v.25 Inhibitory role of cyclic adenosine 3',5'-monophosphate in histamine release from rat peritoneal mast cells in vitro Hayashi,H.;Ichikawa,A.;Saito,T.;Tomita,K.
  11. Pharmacol. v.39 Inhibitory effect of β-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators and mediator releasers in rats Inagaki,N.;Miura,T.;Daikoku,M.;Nagai,H.;Koda,A.
  12. J. Pharmacobiodyn. v.13 Effect of CV-3988, a specific antagonist against platelet activation factor, on homologous passive cutaneous anaphylaxis in the mouse ear Inagaki,N.;Miura,T.;Ohira,K.;Nagai,H.;Xu,W.;Koda,A.
  13. J. Immunol. v.119 Histamine release from rat mast cells by antibodies against rat basophilic leukemia cell membrane Ishizaka,T.;Chang,T.H.;Taggart,M.;Ishizaka,K.
  14. Int. Arch. Allergy Immuniol. v.100 Supernormal histamine release and normal cytotoxic activity of Biege rat mast cells with giant granules Kanemoto,T.J.;Kasugai,T.;Yamatodani,A.;Ushio,H.;Mochizuki,T.;Tohya,K.;Kimura,M.;Nishimura,M.;Kitamura,Y.
  15. Microbiol. Immunol. v.22 A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats Katayama,S.;Shionoya,H.;Ohtake,S.
  16. Pharmacal. Res. v.39 Magnoliae Flos inhibits mast cell-dependent immediate-type allergic reaction Kim,H.M.;Yi,J.M.;Lim,K.S.
  17. Int. Arch. Allergy Immunol. v.82 Mechanism of action of an antiallergic agent: Amlexanox(AA-673), in inhibiting histamine release from mast cells Makino,H.;Saijo,T.;Ashida,Y.;Kuriki,H.H.;Maki,Y.
  18. Annu. Rev. Immunol. v.4 The receptor with high affinity for immunoglobulin E Metzger,H.;Alcaraz,G.;Hohman,R.;Kinet,J.P.;Pribluda,V.;Quarto,R.
  19. Immunol. Lett. v.25 Interaction of substance P, compound 48/80 and mastoparan with α-subunit C-terminal of G protein Mousli,M.C.;Bronner,C.;Bockaert,J.;Rouot,B.;Landry,Y.
  20. FEBS Lett. v.259 Direct activation of GTP-binding regulatory proteins (G proteins) by substance P and compound 48/80 Mousli,M.C.;Bronner,C.;Landry,Y.;Bockaert,J.;Rouot,B.
  21. J. Immunol. v.140 Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate Peachell,P.T.;MacGlashan,D.W.;Lichtenstein,L.M.;Schleimer,R.P.
  22. Nature v.339 Mast cell lines produce limphokines in response to cross-linkage of FcεRI or to calcium ionophores Plaut,M.;Pierce,J.H.;Watson,C.J.;Hanley-Hyde,J.;Nordon,R.P.;Paul,W.E.
  23. J. Allergy Clin. Immunol. v.84 Histamine and its antagonists in asthma Rafferty,P.;Holgate,S.T.
  24. Clin. Exp. Allergy v.20 The pharmacology and mechanisms of action of histamine H₁-antagonists Rimmer,S.J.;Church,M.K.
  25. Pharmaceutical research and development Screening methods for drug evaluation 3 Saito,H.;Nomura,Y.;Suzuki,L.(ed.);Tanaka,H.(ed.);Yajima,H.(ed.)(et al.)
  26. Proc. Natl. Acad. Sci. v.74 Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation Segal,D.M.;Taurog,J.;Metzger,H.
  27. J. Ethnopharmacol. v.66 Effect of Cryptotympana atrata extract on compound 48/80-induced anaphylactic reactions Shin,T.Y.;Park,J.H.;Kim,H.M.
  28. J. Pharmacol. Exp. Ther. v.127 A method for fluorometric assay of histamine in tissues Shore,P.A.;Burkhalter,A.;Cohn,V.H.
  29. J. Immunol. v.114 Modulation of cyclic AMP in purified rat mast cells Ⅰ: responses to pharmacologic, metabolic, and physical stimuli Sullivan,T.J.;Parker,K.L.;Stenson,W.;Parker,C.W.
  30. Planta Med. v.66 Pharmacological effects of urinary products obtained after treatment with Saiboku-To, a herbal medicine for bronchial asthma, on type IV allergic reaction Taniguchi,C.;Homma,M.;Takano,O.;Hirano,T.;Oka,K.;Aoyagi,Y.;Niitsuma,T.;Hayashi,T.
  31. Planta Med. v.62 Myocardial protective effect of honokiol: an active component in Magnolia officinalis Tsai,S.K.;Huang,S.S.;Hong,C.Y.
  32. Chem. Pharm. Bull. v.39 Biologically active constituents of Magnolia salicifolia: inhibitors of induced histamine release from rat mast cells Tsuruga,T.;Ebizuka,Y.;Nakajima,J.;Chun,Y.T.;Noguchi,H.;Iitaka,Y.;Sankawa,U.
  33. J. Pharm. Pharmacol. v.47 Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice Wang,J.P.;Ho,T.F.;Chang,L.C.;Chen,C.C.
  34. Planta Med. v.49 Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects Watanabe,K.;Watanabe,H.;Goto,Y.;Yamaguchi,M.;Yamamoto,N.;Hagino,K.
  35. Immunol. v.139 $^{125}l$-fibrin deposition in lgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells Wershil,B.K.;Mekori,Y.A.;Murakami,T.;Galli,S.J.
  36. Nature v.339 Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to lgE receptor-mediated activation Wodnar-Filipowicz,A.;Heusser,C.H.;Moroni,C.
  37. J. Biol. Chem. v.252 Native heparin from rat peritoneal mast cells Yurt,R.W.;Leid,R.W.;Austen,K.F.
  38. Zhongguo Zhong Yao Za Zhi v.17 Antioxidative effect of chinese drugs Zhou,Y.;Xu,R.